Turbogen Announces Nasdaq Listing Pursuit and Proposed Acquisition of Elbatech Interest

Filing content

Turbogen has entered into a $5 million private placement agreement contingent on Nasdaq listing and is pursuing the acquisition of a 50% interest in Elbatech Ltd. Key transaction terms, including conversion prices for existing debt, are linked to the successful completion of the Nasdaq listing.